November 9, 2016

Post-Grant for Practitioners: Significant PTAB Decisions in BioPharma

The number of IPR petitions filed against biopharma patents at the Patent Trial and Appeal Board continues to steadily increase. Join us for a discussion on Significant PTAB Decisions in BioPharma on November 9, 2016. Fish’s Dorothy Whelan and Tasha Francis provided an update on the most recent biopharma PTAB statistics and decisions. They also discussed the implications of these decisions on the industry and the future impact on biopharma patents.

Dorothy Whelan, Principal
Tasha Francis, Associate

For audio-only (MP3 format), click here to launch in a new window, or right-click and choose “Save link/target as” to download to your computer.

No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.